News

Sampo plc Announces Share Buybacks and Market Updates

Sampo plc Announces Share Buybacks and Market Updates

Sampo plc’s Share Buybacks Update

SAMPO PLC STOCK EXCHANGE RELEASE 19 August 2024 at 8:30 am

Sampo plc’s Share Buyback Summary

On 16 August 2024, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) executed a series of transactions to repurchase its own A shares (ISIN code FI4000552500). Here are the details:

Summary of Share Buybacks

  • Aggregated daily volume (in number of shares): 95,738
  • Daily weighted average price of the purchased shares: 40.78
  • Market (MIC Code): Various

Buyback Volume Breakdown

  • AQEU: 5,472 shares at €40.79
  • CEUX: 37,053 shares at €40.79
  • TQEX: 418 shares at €40.76
  • XHEL: 52,795 shares at €40.78

Note: Prices are averages rounded to two decimal places.

Background of the Share Buyback Program

On 17 June 2024, Sampo announced a strategic share buyback program, which is authorized to reach a maximum of EUR 400 million. This initiative is carried out in accordance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The execution began on 18 June 2024, following approval at Sampo's Annual General Meeting on 25 April 2024.

Impact of the Buybacks on Shareholding

As a result of these transactions, Sampo plc now holds a total of 4,746,746 A shares, representing about 0.95 percent of its entire share structure. This buyback initiative is designed to enhance shareholder value and reaffirm Sampo's commitment to returning capital to its investors.

For additional insights and details regarding the conducted transactions, a comprehensive appendix is included with this announcement.

On behalf of Sampo plc,
Morgan Stanley

Contact Information

For further information, please contact:

Sami Taipalus
Head of Investor Relations
tel. +358 10 516 0030

Distribution of Information

Distribution:
Nasdaq Helsinki
Nasdaq Stockholm
London Stock Exchange
The principal media
FIN-FSA

Frequently Asked Questions

1. What is the significance of Sampo plc's share buyback program?

The share buyback program is intended to enhance shareholder value by returning capital through the acquisition of its own shares in the market.

2. How much capital is Sampo plc authorized to use for this buyback program?

Sampo plc is authorized to conduct a share buyback program with a maximum limit of EUR 400 million.

3. What were the average prices and volumes of shares bought back?

The company repurchased a total of 95,738 shares at a daily weighted average price of €40.78.

4. How does this buyback impact the total shares in circulation?

After the transactions disclosed, Sampo plc owns approximately 0.95 percent of its total shares, which amounts to 4,746,746 A shares.

5. Who should be contacted for more details regarding investor relations?

Sami Taipalus, the Head of Investor Relations, can be reached at +358 10 516 0030 for further information.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 160

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 125

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 116

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Updated Category News Views 221

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 96

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 137

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 167

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 135

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 253

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 44

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

We Energies Recognized for Exceptional Reliability Standards

Updated Category News Views 172

We Energies Celebrated for Excellence in Reliability MILWAUKEE / We Energies has recently been honored with the esteemed 2025 ReliabilityOne® Award, recognizing its superior performance in delivering reliable electric service. This accolade is a testament to the dedication and expertise of its workforce, as well as the strategic investments the company has made to...

Continue Reading
MicroStrategy Options Activity: Insights and Market Trends

Updated Category News Views 59

What Recent Options Activity Says About MicroStrategy Options flow often hints at how the crowd feels before price moves show it. Lately, the tone around MicroStrategy (MSTR) has leaned bearish, a point worth noting if you’re weighing your own trades. The signal isn’t subtle: activity has picked up sharply, and that surge alone can draw in traders who watch sentiment...

Continue Reading
Viactiv Expands Wellness Line with New Chews and Powder

Updated Category News Views 16

Viactiv Expands Beyond Calcium Forget just bone health; Viactiv is stepping up its game. They've gone beyond their trusty calcium chews with something new that targets women’s wellness in a broader sense. Meet the newcomers: Viactiv® CoQ10 CARDIO Complete Soft Chews and Viactiv® Magnesium Glycinate Powder. Ain't that a mouthful? But seriously, these are designed for...

Continue Reading
Rathbones Group Plc's Significant Position in Warpaint London

Updated Category News Views 107

Key Disclosure of Rathbones Group Plc In the financial landscape, transparency is of utmost importance, especially when significant interests in securities come to light. Rathbones Group Plc has provided a crucial disclosure as they maintain an interest in relevant securities of Warpaint London Plc, representing over 1% of their shares. This type of disclosure aligns with...

Continue Reading
Insights into Tryg A/S Q4 2024 Performance and Expectations

Updated Category News Views 260

Overview of Tryg A/S Q4 2024 Newsletter As the end of the year approaches, Tryg A/S is gearing up for a busy period of financial disclosures and investor engagement. In the week commencing mid-December, Tryg will conduct several pre-close analyst calls and meetings. This initiative is designed to prepare stakeholders ahead of the crucial Q4 2024 results release, which is...

Continue Reading